EHCEncompass Health Corp
Slide 1 of 3
Company Overview
Name
Encompass Health Corp
52W High
$127.99
52W Low
$87.45
Market Cap
$11.3B
Dividend Yield
0.625%
Price/earnings
1.26
P/E
1.26
Dividends
No dividend
Sentiment
Score
Very Bullish
85
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
$1.5B
Operating Revenue
$1.5B
Total Gross Profit
$677.8M
Total Operating Income
$243.6M
Net Income
$174.6M
EV to EBITDA
$12.54
EV to Revenue
$2.90
Price to Book value
$0.00
Price to Earnings
$20.82
Additional Data
Selling, General & Admin Expense
$351.8M
Depreciation Expense
$82.4M
Total Operating Expenses
$-434.2M
Interest Expense
$-30.8M
Interest & Investment Income
$1.2M
Other Income / (Expense), net
$5.9M
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
Encompass Health Corp
52W High
$127.99
52W Low
$87.45
Market Cap
$11.3B
Dividend Yield
0.625%
Price/earnings
1.26
P/E
1.26
Dividends
No dividend
Slide 2 of 5
Sentiment
Score
Very Bullish
85
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
$1.5B
Operating Revenue
$1.5B
Total Gross Profit
$677.8M
Total Operating Income
$243.6M
Net Income
$174.6M
EV to EBITDA
$12.54
EV to Revenue
$2.90
Price to Book value
$0.00
Price to Earnings
$20.82
Slide 4 of 5
Additional Data
Selling, General & Admin Expense
$351.8M
Depreciation Expense
$82.4M
Total Operating Expenses
$-434.2M
Interest Expense
$-30.8M
Interest & Investment Income
$1.2M
Other Income / (Expense), net
$5.9M
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
Mark J. Tarr
Location
Alabama, USA
Exchange
NYSE
Website
https://encompasshealth.com
Summary
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services.
Company Info
CEO
Mark J. Tarr
Location
Alabama, USA
Exchange
NYSE
Website
https://encompasshealth.com
Summary
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services.
Company FAQ
@autobot 7 months ago | 2025 - q1
What does this company do? What do they sell? Who are their customers?
Encompass Health Corporation is a leading provider of post-acute healthcare services in the United States. The company operates with a focus on facility-based and home-based services, catering primarily to patients requiring rehabilitation and hospice services following acute medical events such as surgeries or complex medical conditions. The services are designed to help patients recover and regain independence by providing a comprehensive continuum of care that includes both inpatient and home health options. With a network of over 140 hospitals and numerous home health and hospice locations, Encompass Health serves a diverse patient base across 42 states and Puerto Rico. Their commitment to quality care and patient recovery positions them as a significant player in the healthcare services industry, striving to improve the lives of patients while managing the healthcare needs of varied demographics effectively.
What are the company’s main products or services?
Inpatient rehabilitation hospitals providing intensive rehabilitation services for stroke, brain injury, and other complex conditions.,Home health services offering skilled nursing and therapy at patients' homes, aimed at facilitating recovery or management of chronic conditions.,Hospice care services focused on providing comfort and palliative care for terminally ill patients in various settings including homes and hospice facilities.
Who are the company’s main competitors?
Tenet Healthcare Corporation, known for its extensive network of hospitals and outpatient centers.,Kindred Healthcare, a key player in providing long-term acute care and rehabilitation services.,Amedisys, Inc., which competes strongly in the home health and hospice service sectors.
What drives the company’s stock price?
The stock price of Encompass Health is significantly driven by its earnings performance, including growth in earnings per share and revenue. Macro factors such as the general demand for healthcare services and trends in healthcare spending also play a role by influencing the demand for the company's services. Policies and regulatory changes affecting Medicare reimbursements could also drive price volatility. Additionally, strategic expansions into new markets and sectors, such as opening new hospitals, further affect investor sentiment and stock performance. Analysts note the potential impact of operational efficiencies and cost control mechanisms in driving profitability and stock price upward.
What were the major events that happened this quarter?
During the most recent quarter, Encompass Health saw high growth in its revenue and adjusted EBITDA, which was driven by an increase in patient discharge volumes and successful market expansions. The company also continued its growth strategy by adding new hospitals and expanding its facilities to meet the rising demand for healthcare services. They faced challenges from new Medicare Advantage pre-authorization requirements, affecting care access. Notably, Encompass Health's focus on geographic expansion included a comprehensive plan to explore more opportunities in states with relaxed Certificate of Need (CON) laws, like Florida, to capitalize on favorable demographics.
What do you think will happen next quarter?
For the next quarter, Encompass Health anticipates continued growth in revenues and adjusted EBITDA, supported by favorable demographic trends and an increasing demand for healthcare services. They predict a revenue range between $5.8 billion and $5.9 billion, with EBITDA expected between $1.16 billion and $1.20 billion. The company plans to continue its expansion strategy, potentially adding more hospitals and increasing capacity to accommodate more patients. Furthermore, they will emphasize managing construction costs and navigating regulatory changes while aiming to enhance efficiency and patient care quality, maintaining a robust outlook for 2025.
What are the company’s strengths?
Encompass Health's primary strengths include its large network of specialized rehabilitation hospitals and comprehensive home health services across numerous states. The company benefits from a strong brand reputation for quality patient care and rehabilitation outcomes, which fosters trust among patients and stakeholders. Encompass Health's strategic focus on expanding its market reach and providing integrated services positions it well within the healthcare sector. Furthermore, the company's experienced leadership and focus on maintaining operational excellence ensure competitive capabilities against industry peers.
What are the company’s weaknesses?
The company faces potential vulnerabilities related to its dependency on government reimbursements, such as Medicare and Medicaid, which can affect revenue stability amid policy changes. Rising operational costs, including labor and drug expenses, pose a risk to maintaining profitability margins. The challenges posed by regulatory requirements, particularly those impacting pre-authorizations for services, may limit the accessibility and timeliness of care. Additionally, Encompass Health's operations are geographically concentrated in particular states, potentially limiting growth in less-penetrated regions.
What opportunities could the company capitalize on?
Encompass Health has significant opportunities for growth by expanding its hospital network and enhancing its capabilities in both existing and new geographic markets. The increase in the aging population and rising demand for rehabilitation and post-acute services create substantial expansion prospects. To capitalize on these, Encompass Health plans to further integrate telehealth solutions to provide remote monitoring and consultations, enhancing access to their services. Additionally, they aim to strategically partner with local healthcare providers to expand their reach and improve service delivery in underserved areas, taking advantage of regulatory changes such as relaxed Certificate of Need laws.
What risks could impact the company?
The primary risks for Encompass Health include potential changes in healthcare policies and reimbursement rates, which could impact financial performance. Construction costs and regulatory compliance represent operational risks that could affect expansion plans. Additionally, industry-wide challenges such as shortages in skilled healthcare professionals and rising drug costs could impact service delivery capacity and profitability. External economic factors, including economic downturns, could also lead to reduced healthcare spending and insurance coverage, affecting patient volumes and revenues adversely.
What’s the latest news about the company?
Recent news surrounding Encompass Health highlights its growth and strong market performance over the years, with a reported 111% total return to shareholders over the past three years, signaling strong performance satisfaction among investors. The company has announced significant progress in expanding its services, with several new hospitals opening since 2020. Encompass Health also appears to be focusing on strategic growth opportunities, including potential market expansions and improvements in patient care quality. Furthermore, industry analysts have maintained a positive outlook on the company, recommending it as a strategic buy due to its operational strengths and capacity to adapt to market changes.
What market trends are affecting the company?
Broad market trends affecting Encompass Health include a general shift in investor focus towards technology stocks, causing healthcare stocks to underperform recently. However, the healthcare sector remains attractive due to the solid demand for services and technological advancements enhancing care delivery. Policy changes impact overall sector dynamics by affecting areas like reimbursement and regulatory compliance. Moreover, as the population ages and healthcare needs grow, companies like Encompass Health are poised to benefit from an increasing focus on patient-centered, post-acute care solutions that match evolving patient demographics.
Price change
$103.37
